Israeli company NovaSight diagnoses and treats lazy eye and concentration problems by monitoring eye movement.
The Israeli company develops home devices for diagnosing sleep apnea.
RedHill's share price has fallen 45% since it reported the results of the Phase III trial of its drug for Crohn's Disease.
The pharmaceutical company will focus on its generic and OTC operations.
InsuLine said that IBI's investment was strategic for its non-banking credit activity.
The 10 startups were chosen from 525 candidates for the MassChallenge program.
Beersheva-based DiA’s automated AI and imaging analysis technology delivers accurate and reproducible imaging analysis of ultrasound images.
The company met its main endpoint in the advanced trial of its treatment for Crohn's Disease, but its share price fell anyway.
CEO Kare Schultz has set sights on 2020 for a return to revenue growth, and Credit Suisse finds reasons for optimism.
A trial of the company's drug for the neurodegenerative condition known Lou Gehrig's Disease will begin at Hadassah Ein Karem Medical Center.
The agreement with Micro-Tech Endoscopy is for Medigus's Ultrasonic Surgical Endostapler (MUSE) system.
The Israeli company develops material for infection-proof dental fillings.
Qingxi Huang tells "Globes" about plans to invest in hundreds of Israeli companies through ICB Biotechnology Investments.
Prof. Steven Lamm, in Israel as a consultant to Itamar Medical, tells "Globes" that sleep is more important than physical exercise.
Biogen CEO Michel Vounatsos seeks synergy between pharma and technology, and found kindred spirits in Israel.
Restrictions on foreign investors and the government's reluctance to approve exports are inhibiting growth in Israel's medical cannabis sector.
Lior Shalev, grandson of Teva founder Eli Hurvitz, targets the 'double bottom line' - both economic and social profit.
The company's share price has risen 118% since Kare Schultz became CEO in November, and 23.5% in the past month. What has changed?
Amai Proteins designs sweet proteins that do not affect the sugar levels in the blood.
Cannabics seeks to match cannabis compounds to treatment of specific tumors.